Literature DB >> 17849174

Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells.

Xue-Ping Zhang1, Gang Zheng, Lian Zou, Hui-Ling Liu, Li-Hong Hou, Peng Zhou, Dan-Dan Yin, Qi-Jun Zheng, Liang Liang, Su-Zhen Zhang, Lei Feng, Li-Bo Yao, An-Gang Yang, Hua Han, Jing-Yuan Chen.   

Abstract

Since Notch signaling plays a critical role in stem cells and oncogenesis, we hypothesized that Notch signaling might play roles in cancer stem cells and cancer cells with a stem cell phenotype. In this study, we accessed potential functions of the Notch pathway in the formation of cancer stem cells using human glioma. Using RT-PCR, we found that most human astrogliomas of different grades expressed moderate to high level of Notch receptors and ligands. mRNA of Hes5 but not Hes1, both of which are major downstream molecules of the Notch pathway, was also detected. In human glioma cell lines BT325, U251, SHG-44, and U87, mRNA encoding different types of Notch receptors were detected, but active form of Notch1 (NIC) was only detected in SHG-44 and U87 by Western blot. Interestingly, proliferation of these two glioma cell lines appeared faster than that of the other two lines in which NIC was not detected. We have over-expressed NIC of Notch1 in SHG-44 cells by constitutive transfection to evaluate the effects of Notch signaling on glioma cells. Our results showed that over-expression of NIC in SHG-44 cells promoted the growth and the colony-forming activity of SHG-44 cells. Interestingly, over-expression of NIC increased the formation neurosphere-like colonies in the presence of growth factors. These colonies expressed nestin, and could be induced to cells expressing neuron-, astrocyte-, or oligodendrocyte-specific markers, consistent with phenotypes of neural stem cells. These data suggest that Notch signaling promote the formation of cancer stem cell-like cells in human glioma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849174     DOI: 10.1007/s11010-007-9589-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.

Authors:  S J Morrison; S E Perez; Z Qiao; J M Verdi; C Hicks; G Weinmaster; D J Anderson
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.

Authors:  L J Rubinstein
Journal:  J Neurosurg       Date:  1985-06       Impact factor: 5.115

3.  Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate.

Authors:  K Tanigaki; F Nogaki; J Takahashi; K Tashiro; H Kurooka; T Honjo
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 4.  Nestin expression--a property of multi-lineage progenitor cells?

Authors:  C Wiese; A Rolletschek; G Kania; P Blyszczuk; K V Tarasov; Y Tarasova; R P Wersto; K R Boheler; A M Wobus
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

5.  The expression and function of Notch pathway genes in the developing rat eye.

Authors:  Z Z Bao; C L Cepko
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

7.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

8.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

9.  An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells.

Authors:  J S Nye; R Kopan; R Axel
Journal:  Development       Date:  1994-09       Impact factor: 6.868

10.  Notch1 control of oligodendrocyte differentiation in the spinal cord.

Authors:  Stephane Genoud; Corinna Lappe-Siefke; Sandra Goebbels; Freddy Radtke; Michel Aguet; Steven S Scherer; Ueli Suter; Klaus-Armin Nave; Ned Mantei
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  62 in total

1.  Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.

Authors:  Koos E Hovinga; Fumiko Shimizu; Rong Wang; Georgia Panagiotakos; Maartje Van Der Heijden; Hamideh Moayedpardazi; Ana Sofia Correia; Denis Soulet; Tamara Major; Jayanthi Menon; Viviane Tabar
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

Review 2.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

3.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

4.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.

Authors:  Eli E Bar; Alex Lin; Vasiliki Mahairaki; William Matsui; Charles G Eberhart
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

5.  Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells.

Authors:  Shingo Tanaka; Mitsutoshi Nakada; Daisuke Yamada; Ichiro Nakano; Tomoki Todo; Yasushi Ino; Takayuki Hoshii; Yuko Tadokoro; Kumiko Ohta; Mohamed A E Ali; Yutaka Hayashi; Jun-ichiro Hamada; Atsushi Hirao
Journal:  J Neurooncol       Date:  2014-10-08       Impact factor: 4.130

Review 6.  Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Brain Pathol       Date:  2011-07-07       Impact factor: 6.508

Review 7.  Cancer stem cells and radioresistance.

Authors:  Kiera Rycaj; Dean G Tang
Journal:  Int J Radiat Biol       Date:  2014-03-07       Impact factor: 2.694

8.  NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Authors:  Xing Fan; Leila Khaki; Thant S Zhu; Mary E Soules; Caroline E Talsma; Naheed Gul; Cheryl Koh; Jiangyang Zhang; Yue-Ming Li; Jarek Maciaczyk; Guido Nikkhah; Francesco Dimeco; Sara Piccirillo; Angelo L Vescovi; Charles G Eberhart
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

Review 9.  Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways.

Authors:  Zhizhong Li; Hui Wang; Christine E Eyler; Anita B Hjelmeland; Jeremy N Rich
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

10.  Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.

Authors:  Khaled A Hassan; Luo Wang; Hasan Korkaya; Guoan Chen; Ivan Maillard; David G Beer; Gregory P Kalemkerian; Max S Wicha
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.